Susanna Francke Rodau has worked in life science for most of her professional life, both with medtech and pharmaceuticals in companies such as Pfizer and Roche Diagnostics. She most recently came from a position as head of the Neuro Solutions business area at Elekta.
Now she is changing perspectives.
“I have worked on the operational side for 20 ...
Investment CEO: “The Nordics are outstanding in creating successful medtech companies”
Since the beginning of last month, Susanna Francke Rodau has been a partner and the new CEO of Segulah Medical Acceleration, which invests in medical technology. In an interview she tells about which companies the investment company prefers to invest in, which companies she believes in the most in the portfolio and why she accepted the new position.
Susanna Francke Rodau is the newly appointed CEO of Segulah Medical Acceleration. Photo: Karl Gabor/Segulah Medical Acceleration
Vill du få åtkomst till allt?
Prova 30 dagar för 0 kr.
Inga bindningstider eller kortuppgifter krävs.
Prova nu
Köp en prenumeration
Utforska våra prenumerationslösningar och välj den som passar dina behov.
Välj din prenumeration